Early Evidence of Safety, Clinical Benefit, and Pharmacokinetics of Roflumilast Cream 0.3% Once Daily for Treatment of Mild or Moderate Plaque Psoriasis in Children Aged 2–11 Years

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: Adelaide A. Hebert, Shireen V. Guide, Vlada Groysman, Mercedes E. Gonzalez, Daisy Blanco, Vivian Laquer, Melissa S. Seal, Archie Thurston, David Krupa, Scott Snyder, Patrick Burnett, David H. Chu, David R. Berk, Robert C. Higham
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items